Product Program year 2020 Source: CMS Open Payments

Flumist Quadrivalent

Drug Respiratory

NDC 66019-306-10

Open in the dashboard

General payments

$2,635,024

21 payments

Research payments

$281,440

3 payments

Through program year 2020, $2,635,024 in general payments and $281,440 in research payments were reported against Flumist Quadrivalent (Respiratory).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

4 rows
Year Kind Amount Payments
2020 General $2,633,621 6
2020 Research $1,000 1
2019 General $1,403 15
2019 Research $280,440 2

Breakdown

Who paid General payments · program years 2019–2020
  1. AstraZeneca Pharmaceuticals LP $2,635,024 21 payments
Top recipients General payments · program year 2020
  1. Univ Of Mi Hospitals & Hlth Ctrs Teaching hospital · MI $2,631,966 100% · 3 payments
  2. Ravi Jhaveri Pediatric Infectious Diseases · Chicago, IL $1,125 <1% · 1 payment
  3. Graham Barden Pediatrics · New Bern, NC $512 <1% · 1 payment
  4. Belleitha Lambkin-Alexander Pediatrics · West Palm Beach, FL $18 <1% · 1 payment

Each share is of general payments naming this product in 2020.

Specialties paid General payments · program year 2020
  1. Pediatric Infectious Diseases Pediatrics $1,125 68% · 1 practitioner
  2. Pediatrics $530 32% · 2 practitioners

Each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

Where the money went General payments · program year 2020
  1. Michigan $2,631,966 100% · 1 recipient
  2. Illinois $1,125 <1% · 1 recipient
  3. North Carolina $512 <1% · 1 recipient
  4. Florida $18 <1% · 1 recipient

Each share is of general payments naming this product in 2020 where a state was reported.

21 general · 3 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record